DE3576649D1 - Prostaglandine zur behandlung von gehirnanoxie. - Google Patents
Prostaglandine zur behandlung von gehirnanoxie.Info
- Publication number
- DE3576649D1 DE3576649D1 DE8585305203T DE3576649T DE3576649D1 DE 3576649 D1 DE3576649 D1 DE 3576649D1 DE 8585305203 T DE8585305203 T DE 8585305203T DE 3576649 T DE3576649 T DE 3576649T DE 3576649 D1 DE3576649 D1 DE 3576649D1
- Authority
- DE
- Germany
- Prior art keywords
- anoxy
- prostaglandine
- treating brain
- sub
- pgl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004556 brain Anatomy 0.000 title 1
- 206010002660 Anoxia Diseases 0.000 abstract 1
- 241000976983 Anoxia Species 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000007953 anoxia Effects 0.000 abstract 1
- 210000004958 brain cell Anatomy 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/08—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/08—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
- C07C35/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings with unsaturation only outside the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/08—Saturated compounds having a carboxyl group bound to a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15271884A JPS6130519A (ja) | 1984-07-23 | 1984-07-23 | 脳神経細胞の酸素欠乏性疾患治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3576649D1 true DE3576649D1 (de) | 1990-04-26 |
Family
ID=15546633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585305203T Expired - Lifetime DE3576649D1 (de) | 1984-07-23 | 1985-07-22 | Prostaglandine zur behandlung von gehirnanoxie. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4812475A (de) |
EP (1) | EP0169725B1 (de) |
JP (1) | JPS6130519A (de) |
AT (1) | ATE51151T1 (de) |
DE (1) | DE3576649D1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9815785D0 (en) * | 1998-07-20 | 1998-09-16 | Cerebrus Ltd | Chemical compounds |
DK2465537T3 (en) | 2002-10-10 | 2016-09-19 | Ono Pharmaceutical Co | MICROSPHERE INCLUDING ONO-1301 |
ES2525748T3 (es) | 2009-11-13 | 2014-12-29 | Toray Industries, Inc. | Agente terapéutico o profiláctico para la diabetes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54125653A (en) * | 1978-03-18 | 1979-09-29 | Ono Pharmaceut Co Ltd | Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent |
JPS55111465A (en) * | 1979-02-20 | 1980-08-28 | Ono Pharmaceut Co Ltd | Prostaglandin i2 analog and its preparation |
DE2907118A1 (de) * | 1979-02-20 | 1980-09-04 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
JPS5973522A (ja) * | 1982-10-20 | 1984-04-25 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患治療剤 |
DE3315356A1 (de) * | 1982-04-30 | 1983-11-17 | Ono Pharmaceutical Co. Ltd., Osaka | Verwendung von prostaglandinanalogen |
JPS58192821A (ja) * | 1982-04-30 | 1983-11-10 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患の治療剤 |
-
1984
- 1984-07-23 JP JP15271884A patent/JPS6130519A/ja active Granted
-
1985
- 1985-07-22 EP EP85305203A patent/EP0169725B1/de not_active Expired - Lifetime
- 1985-07-22 DE DE8585305203T patent/DE3576649D1/de not_active Expired - Lifetime
- 1985-07-22 AT AT85305203T patent/ATE51151T1/de not_active IP Right Cessation
-
1986
- 1986-11-25 US US06/935,153 patent/US4812475A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0169725A3 (en) | 1986-11-12 |
EP0169725A2 (de) | 1986-01-29 |
JPH0443053B2 (de) | 1992-07-15 |
JPS6130519A (ja) | 1986-02-12 |
US4812475A (en) | 1989-03-14 |
EP0169725B1 (de) | 1990-03-21 |
ATE51151T1 (de) | 1990-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES534624A0 (es) | Un procedimiento para preparar un derivado de 1,8-naftiridina | |
DK0447285T3 (da) | Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
NO992549L (no) | Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav | |
ES525358A0 (es) | Procedimiento para la fabricacion de 4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridinas | |
ES551337A0 (es) | Metodo de preparar derivados de b-carbolin-3-oxadiazolilo | |
NO840595L (no) | Fremgangsmaate ved fremstilling av nye carbacycliner | |
DE3675226D1 (de) | Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide. | |
FI913067A0 (fi) | Bisfosfonsyraderivat, deras framstaellning och anvaendning. | |
DE3576649D1 (de) | Prostaglandine zur behandlung von gehirnanoxie. | |
ES8400752A1 (es) | "procedimiento para la preparacion de nuevos derivados de ciclofosfamida". | |
AU565492B2 (en) | 4-phenyl-4-oxo-buten-2-oic acids | |
BR8502885A (pt) | Processo para preparar acido azetidino-3-carboxilico,seus derivados e usos | |
ES523890A0 (es) | Un procedimiento para preparar derivados de penem. | |
SE8402649L (sv) | Framstellning av 1,8-dihydroxi-10-acyl-9-antroner | |
FR2514006B1 (de) | ||
ES474230A1 (es) | Procedimiento para preparar derivados de acido anilinoalco- hiltioico | |
ATE40677T1 (de) | Diaminderivate. | |
FI844184A0 (fi) | Isokinolinderivat och foerfarande foer framstaellning daerav. | |
ES2076212T3 (es) | Derivado de maleimida, procedimiento para la preparacion del mismo, y fungicida agricola y horticola que contiene dicho derivado de maleimida como un ingrediente activo. | |
ES8506035A1 (es) | Procedimiento para preparar nuevas sales de bis-alquilfosfonico de n-fosfonometilglicina | |
ATE64095T1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
ATE86629T1 (de) | 4-piperidincarboxamid-derivate. | |
ATE4049T1 (de) | Verfahren zum herstellen von chlorphenolen. | |
ES8303381A1 (es) | Procedimiento para la fabricacion de un compuesto de fenil- 1,3-perhidrotiacina-4-ona, 2-substituida | |
BG37524A3 (en) | Method for preparing 1, 5- benzothiazepines derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |